Mon, August 13, 2018
Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018
Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018
Thu, August 2, 2018
Wed, August 1, 2018
Tue, July 31, 2018

Thomas Shrader Initiated (BIIB) at Strong Buy and Held Target at $394 on, Aug 7th, 2018


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-394-on-aug-7th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Thomas Shrader of Stifel, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $394 on, Aug 7th, 2018.

Thomas has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 2 agree with Thomas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $320 on, Wednesday, July 25th, 2018
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $348 on, Wednesday, July 25th, 2018


These are the ratings of the 4 analyists that currently disagree with Thomas


  • Carter Gould of "UBS" Maintained at Strong Buy with Increased Target to $395 on, Thursday, July 26th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $392 on, Wednesday, July 25th, 2018
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018

Publication Contributing Sources